优化全球结直肠癌筛查质量
本文综述了结直肠癌筛查全流程中操作者与系统依赖性差异,指出任一环节失败均可导致不必要的并发症和死亡。美欧已就结肠镜筛查的实施与测量以及非结肠镜筛查项目的质量保证提出详细建议,质量改进科学证实更高质量可预防癌症发生与死亡。
要点
- 筛查是多步骤过程,任一环节失败均可致不必要的并发症和死亡。
- 美欧已发布结肠镜筛查实施与测量的详细综合建议。
- 质量改进需在系统、提供者和个体层面同时推进。
核心结论
- 筛查后行结肠镜息肉切除术(恶性病变行手术)可预防结直肠癌发生和死亡。
- 筛查过程各环节的有效应用存在差异,任一单一步骤失败均可能导致不必要的并发症和死亡。
- 质量改进已被证实为有效科学,明确证据表明更高质量可预防癌症发生和癌症死亡。
研究设计与样本
- 综述,回顾测量和改善结直肠癌筛查质量的重要方面。
主要发现
- 筛查过程各环节的有效应用存在差异,操作者和系统依赖性表现存在变化。
- 美欧已就结肠镜筛查应如何实施和测量提出详细、全面的建议。
- 已为非以结肠镜为基础的筛查项目提供质量保证指导,包括最大化依从性的策略。
临床怎么用
- 质量改进须在系统、提供者和个体层面同时推进,以最大化任何人群的筛查获益。
- 应关注操作者和系统依赖性表现差异,参照美欧详细建议实施和测量结肠镜筛查。
- 非结肠镜筛查项目应参照质量保证指导,包括最大化依从性的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Screening, followed by colonoscopic polypectomy (or surgery for malignant lesions), prevents incident colorectal cancer and mortality. However, there are variations in effective application of nearly every aspect of the screening process. Screening is a multistep process, and failure in any single step could result in unnecessary morbidity and mortality. Awareness of variations in operator- and system-dependent performance has led to detailed, comprehensive recommendations in the United States and Europe on how colonoscopy screening should be performed and measured. Likewise, guidance has been provided on quality assurance for nonprimary colonoscopy-based screening programs, including strategies to maximize adherence. Quality improvement is now a validated science, and there is clear evidence that higher quality prevents incident cancer and cancer death. Quality must be addressed at the levels of the system, provider, and individuals, to maximize the benefits of screening for any population. We review the important aspects of measuring and improving the quality of colorectal cancer screening.
引用
- Kaminski MF, Robertson DJ, Senore C, et al. Optimizing the Quality of Colorectal Cancer Screening Worldwide. Gastroenterology. 2019. PMID: 31759062. doi:10.1053/j.gastro.2019.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。